APhA, its pharmacy partners, and community pharmacies have long argued that PBMs working with Medicare Part D plan sponsors’ use of retroactive direct and indirect remuneration (DIR) fees cheats beneficiaries, forces pharmacies to close their doors, and endangers access to pharmacist-provided care.
Rachel Balick